EVALUATION OF THE EFFECTIVENESS OF CONTINUOUS HEMOFILTRATION USING ADSORPTION MEMBRANES ON THE MANIFESTATION AND OUTCOMES OF TREATMENT OF SEPTIC SHOCK IN SEVERE BURN PATIENTS

Tuấn Hưng Ngô1,2, , Như Lâm Nguyễn1,2, Hải An Nguyễn1,2, Đình Hùng Trần1,2
1 Bộ môn Bỏng và Y học Thảm họa, Học viện Quân y
2 Bệnh viện Bỏng Quốc gia Lê Hữu Trác

Main Article Content

Abstract

Objectives: Evaluation of the effectiveness of continuous hemofiltration using adsorption membranes (HFA) on the manifestation and outcomes of treatment of septic shock in severe burn patients. Subjects and methods: Prospective, interventional study of 55 episodes of septic shock in 38 severely burned patients (16-60 years old) receiving continuous hemofiltration with oXiris membranes, treated at the Department of Emergency Resuscitation, Le Huu Trac National Burn Hospital from January 2023 to June 2024. Study time points: at diagnosis of septic shock (T1), time of HFA (T2), after 6 hours of HFA (T3), 12 hours of HFA (T4), 24 hours of HFA (T5) and 48 hours of HFA (T6). Results: The mortality rate was 60.53. In 55 episodes of septic shock, there were 36 shock episodes escapes (65.45%). During HFA, there was a significant reduction in SOFA score (T2: 8 (7 – 9), T4: 7 (6 – 8), T5: 6 (5 – 8), T6: 5 (2 – 8), p < 0.001), Vasoactive -Inotropic Score (T2: 30 (20 – 50), T3: 20 (15 – 40), T4: 15 (10 – 30), T5: 5 (3 – 30), T6: 0 (0 – 20), p < 0.001) and arterial blood lactate concentration (T1: 2.6 (2.3 – 3.4) mmol/L, T3: 1.9 (1.3 – 2.6) mmol/L, T4: 1.9 (1.2 – 2.4) mmol/L, T5: 1 .8 (1.3 – 2.5) mmol/L, T6: 1.8 (1.3 – 2.5) mmol/L, p < 0.001). Conclusion: Continuous hemofiltration with adsorption membrane significantly reduced SOFA, Vasoactive -Inotropic Score and arterial blood lactate concentration.

Article Details

References

1. Bottiroli M, Monti G, Pinciroli R, et al. Prevalence and clinical significance of early high endotoxin activity in septic shock: An observational study. Journal of critical care. 2018; 41: 124-129.
2. Adamik B, Zielinski S, Smiechowicz J, et al. Endotoxin elimination in patients with septic shock: An observation study. Archivum immunologiae et therapiae experimentalis. 2015; 63(6):475-483.
3. Wang G, He Y, Guo Q, et al. Continuous renal replacement therapy with the adsorptive oXiris filter may be associated with the lower 28-day mortality in sepsis: A systematic review and meta-analysis. Critical Care. 2023; 27(1):275.
4. Turani F, Martini S. Extracorporeal blood purification with the oxiris membrane in septic shock. Management of Shock-Recent Advances, IntechOpen. 2022; 4.
5. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016; 315(8):801-810.
6. İnotropik V. The use of vasoactive-inotropic score in adult patients with septic shock in intensive care. Yoğun Bakım Derg. 2019; 10(1): 23-30.
7. Lumlertgul N, Srisawat N. The haemodynamic effects of oXiris haemofilter in septic shock patients requiring renal support: A single-centre experience. The International journal of artificial organs. 2021; 44(1):17-24.
8. Fang Q, Qiqiang L, Man H. Treatment of sepsis-associated acute kidney injury in severely burned patients using oXiris® Enhanced blood purification protocol: A single-center study. Chin J Emerg Med. 2020; 29(12):1572-1576.
9. Mariano F, Greco D, Depetris N, et al. CytoSorb® in burn patients with septic shock and acute kidney injury on continuous kidney replacement therapy was associated with improved clinical outcome and survival. Burns. 2024; 50(5):1213-1222.
10. Mariano F, Depetris N, Malvasio V, et al. Coupled-plasma filtration and adsorption for severe burn patients with septic shock and acute kidney injury treated with renal replacement therapy. Burns. 2020; 46(1):190-198.